Mednow completes acquisition of Infusicare specialty pharmacy
Canadian digital pharmacy Mednow has wrapped up its acquisition of Infusicare Canada Inc., a specialty pharmacy focused on biologic pharmaceuticals, for C$1.85 million in cash.
The data comes months quickly after the enterprise launched its possess telehealth help that enhances its digital pharmacy choices.
WHY IT Points
Mednow is positioning this most up-to-date acquisition as a approach to strengthen its existence within the biologic drug sector and develop its functionality for actual same-working day supply.
Biologics, a type of medication constructed from residing organisms or their cells, are a escalating course of medicines, however they are often high-priced.
“Mednow proceeds to realize its imaginative and prescient of connecting all folks of Canada with receive to wonderful care, by the use of the acquisition of Infusicare,” Karim Nassar, CEO of Mednow, claimed in a assertion.
“Introducing Infusicare, a specialty pharmacy providing biologic medication, enhances our technique to accelerating our tactic of entire-service choices by way of each of these pure development and mergers and acquisitions. [The] specialty pharmacy will combine very properly into our digital pharmacy, which presents unique therapy adherence options along with psychological wellbeing steering, epigenetic testing and males’s wellness.”
THE Larger Improvement
Mednow went basic public earlier than this calendar 12 months and started investing on the TSX Enterprise Commerce in March.
Exterior Mednow’s most the most recent acquisition, to start with declared remaining thirty day interval, the corporate additionally scooped up family therapy provider Medvisit and a further on-line pharmacy in British Columbia this yr. It may be additionally invested in digital therapy enterprise Doko Skilled medical, which operates within the U.S. and Canada.
A wide range of companies supply digital pharmacy knowledgeable providers on the sector, and quite a few of them have expanded into telehealth.
Earlier than this thirty day interval, Truepill introduced packages so as to add a COVID-19 digital therapy system, simply months instantly after the company scored $142 million in Sequence D financing.
Sesame, a direct-payment healthcare market, launched its particular person digital pharmacy options in late August by way of a partnership with Truepill.
Many others in the home contain Amazon, which rolled out its Amazon Pharmacy retailer a few yr in the past Alto, which earlier calendar 12 months partnered with Hims & Hers and scored $250 million in Sequence D funding and Medly, which closed a $100 million Sequence B spherical in 2020.
